Skip to main content
Erschienen in: Obesity Surgery 7/2009

01.07.2009 | Clinical Research

Evidence of Thromboembolism Prophylaxis in Bariatric Surgery—Results of a Quality Assurance Trial in Bariatric Surgery in Germany from 2005 to 2007 and Review of the Literature

verfasst von: Christine Stroh, D. Birk, R. Flade- Kuthe, M. Frenken, B. Herbig, S. Höhne, H. Köhler, V. Lange, K. Ludwig, R. Matkowitz, G. Meyer, P. Pick, Th. Horbach, S. Krause, L. Schäfer, M. Schlensak, E. Shang, T. Sonnenberg, M. Susewind, H. Voigt, R. Weiner, S. Wolff, A. M. Wolf, U. Schmidt, F. Meyer, H. Lippert, Th. Manger, Study Group Obesity Surgery

Erschienen in: Obesity Surgery | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Since January 1st, 2005, the current situation for bariatric surgery has been examined by means of a voluntary quality assurance study in Germany with a multicenter design in which 38 hospitals and surgical departments participated. The data are registered in cooperation with the Institute of Quality Assurance in Surgery at the Otto-von-Guericke University of Magdeburg (Germany).

Methods

Data describing peri-interventional characteristics were prospectively documented in an internet online data registry. All primary bariatric procedures performed since January 1st, 2005, were registered. In addition, reoperations in patients who had previously undergone primary surgical intervention were included. As a representative excerpt from the overall prospective multicenter observational study on obesity surgery, data on the type, regimen, and time course of deep venous thrombosis (DVT) prophylaxis were documented. From the number and spectrum of complications, the incidences of clinically manifest DVT or pulmonary embolism (PE) were derived during the in-hospital course and follow-up in conjunction with the type of surgical procedure and body mass index (BMI).

Results

Overall, 3,122 bariatric procedures were performed at 38 German hospitals between January 2005 and December 2007. These procedures were subdivided into 2,869 primary operations and 253 revisions (sex ratio, male to female = 25.6:74.4%). The average BMI of all patients was 48.5 kg/m² in 2005, 48.4 kg/m² in 2006, and 48.0 kg/m² in 2007. In 2005 and 2006, gastric banding (GB) was the most commonly performed operation, followed by Roux-en-Y gastric bypass (RYGBP). In 2007, RYGBP was carried out in 42.1% of all bariatric procedures. Interestingly, the incidence of deep venous thrombosis (DVT) was only 0.06%, whereas PE occurred in 0.06% of patients only after hospital discharge. The DVT prophylaxis protocol used has been changed for the last 2 years: the majority of patients with a BMI above 50 kg/m² received low-molecular-weight heparin twice a day.

Conclusion

In Germany, a trend from GB to sleeve gastrectomy (SG) and malabsorptive approach has been evaluated. This trend is associated with differences of the DVT prophylaxis regimen in the profile of bariatric surgical patients depending on BMI and the type of bariatric procedure. Despite the low incidence of DVT and pulmonary embolism (PE) detected, there is a lack of evidence on a reasonable regimen for sufficient DVT prophylaxis in bariatric surgery; instead, there are only recommendations from the guidelines and statements of a specific medical society. Therefore, prospective studies are necessary to determine the optimal DVT prophylaxis for bariatric surgical patients as well as obese patients undergoing surgery.
Literatur
1.
Zurück zum Zitat Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30.CrossRefPubMed Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30.CrossRefPubMed
2.
Zurück zum Zitat James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3–8.CrossRefPubMed James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3–8.CrossRefPubMed
3.
Zurück zum Zitat Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRefPubMed Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRefPubMed
4.
Zurück zum Zitat Hartel W, Euche A, Koppenhagen K et al. Leitlinien zur stationären und ambulanten Thrombembolie-Prophylaxe in der Chirurgie. Expertengespräche zur Thrombembolie-Prophylaxe 1997 und 2000. Beilage zu den Mitteilungen der Deutschen Gesellschaft für Chirurgie 2000;3. Hartel W, Euche A, Koppenhagen K et al. Leitlinien zur stationären und ambulanten Thrombembolie-Prophylaxe in der Chirurgie. Expertengespräche zur Thrombembolie-Prophylaxe 1997 und 2000. Beilage zu den Mitteilungen der Deutschen Gesellschaft für Chirurgie 2000;3.
5.
Zurück zum Zitat Partsch H, Blättler W. Leitlinien zur Thrombembolie-Prophylaxe. Phlebologie. 2000;29:106–13.CrossRef Partsch H, Blättler W. Leitlinien zur Thrombembolie-Prophylaxe. Phlebologie. 2000;29:106–13.CrossRef
6.
Zurück zum Zitat International Consensus Statement. Prevention and treatment of venous thromboembolism. Int Angiol. 2006;25:101–61. International Consensus Statement. Prevention and treatment of venous thromboembolism. Int Angiol. 2006;25:101–61.
7.
Zurück zum Zitat Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis. 2007;3:494–5.CrossRef Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis. 2007;3:494–5.CrossRef
8.
Zurück zum Zitat Martin LF, Gouda BP. What we know and don’t know about deep venous thrombosis and pulmonary embolism!. Obes Surg. 2005;15:565–6. 1.CrossRefPubMed Martin LF, Gouda BP. What we know and don’t know about deep venous thrombosis and pulmonary embolism!. Obes Surg. 2005;15:565–6. 1.CrossRefPubMed
9.
Zurück zum Zitat Stroh C, Birk D, Flade-Kuthe R, Frenken M, Herbig B, Höhne S, Köhler H, Lange V, Ludwig K, Matkowitz R, Meyer G, Meyer F, Pick P, Horbach T, Krause S, Schäfer L, Schlensak M, Shang E, Sonnenberg T, Susewind M, Voigt H, Weiner R, Wolff S, Lippert H, Wolf AM, Schmidt U, Manger T; Bariatric Surgery Working Group. A nationwide survey on bariatric surgery in Germany—results 2005–2007. Obes Surg. 2008 (in press). Stroh C, Birk D, Flade-Kuthe R, Frenken M, Herbig B, Höhne S, Köhler H, Lange V, Ludwig K, Matkowitz R, Meyer G, Meyer F, Pick P, Horbach T, Krause S, Schäfer L, Schlensak M, Shang E, Sonnenberg T, Susewind M, Voigt H, Weiner R, Wolff S, Lippert H, Wolf AM, Schmidt U, Manger T; Bariatric Surgery Working Group. A nationwide survey on bariatric surgery in Germany—results 2005–2007. Obes Surg. 2008 (in press).
10.
Zurück zum Zitat Stroh C, Manger T. Studie zur Qualitätskontrolle der operativen Therapie der Adipositas. Mitt Dtsch Ges Chir. 2004;33:389–91. Stroh C, Manger T. Studie zur Qualitätskontrolle der operativen Therapie der Adipositas. Mitt Dtsch Ges Chir. 2004;33:389–91.
11.
Zurück zum Zitat Blaszyk H, Wollan PC, Witkiewicz AK, Bjornsson J. Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors. Virchows Arch. 1999;434:529–32.CrossRefPubMed Blaszyk H, Wollan PC, Witkiewicz AK, Bjornsson J. Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors. Virchows Arch. 1999;434:529–32.CrossRefPubMed
12.
Zurück zum Zitat Eriksson S, Backman L, Ljungstrom K. The incidence of clinical postoperative thrombosis after gastric surgery for morbid obesity during 16 years. Obes Surg. 1997;7:332–6.CrossRefPubMed Eriksson S, Backman L, Ljungstrom K. The incidence of clinical postoperative thrombosis after gastric surgery for morbid obesity during 16 years. Obes Surg. 1997;7:332–6.CrossRefPubMed
13.
Zurück zum Zitat Hamad GG, Smith-Choban P. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving Enoxaparin (PROBE) study. Obes Surg. 2005;15:1368–74.CrossRefPubMed Hamad GG, Smith-Choban P. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving Enoxaparin (PROBE) study. Obes Surg. 2005;15:1368–74.CrossRefPubMed
14.
Zurück zum Zitat Poulose BK, Griffin MR, Zhu Y, Smalley W, Richards WO, Wright JK, et al. National analysis of adverse patient safety for events in bariatric surgery. Am Surg. 2005;71:406–13.PubMed Poulose BK, Griffin MR, Zhu Y, Smalley W, Richards WO, Wright JK, et al. National analysis of adverse patient safety for events in bariatric surgery. Am Surg. 2005;71:406–13.PubMed
15.
Zurück zum Zitat Westling A, Bergquist D, Boström A, Karacagil S, Gustavsson S. Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg. 2002;26:470–3.CrossRefPubMed Westling A, Bergquist D, Boström A, Karacagil S, Gustavsson S. Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg. 2002;26:470–3.CrossRefPubMed
16.
Zurück zum Zitat Fernandez A, DeMaria E, Tichansky D. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698–703.CrossRefPubMedPubMedCentral Fernandez A, DeMaria E, Tichansky D. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698–703.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134–40.CrossRefPubMed DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134–40.CrossRefPubMed
18.
Zurück zum Zitat Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med. 2002;126:1091–5.PubMed Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med. 2002;126:1091–5.PubMed
19.
Zurück zum Zitat Nguyen NT, Owings JT, Gosselin R, Pevec WC, Lee SJ, Goldman C, et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg. 2001;136:909–16.CrossRefPubMed Nguyen NT, Owings JT, Gosselin R, Pevec WC, Lee SJ, Goldman C, et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg. 2001;136:909–16.CrossRefPubMed
20.
Zurück zum Zitat Miller MT, Rovito PF. An approach to venous thromboembolism prophylaxis in laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2004;14(6):731–7.CrossRefPubMed Miller MT, Rovito PF. An approach to venous thromboembolism prophylaxis in laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2004;14(6):731–7.CrossRefPubMed
21.
Zurück zum Zitat Sobolewski AP, Deshmukh RM, Brunson BL, McDevitt DT, VanWagenen TM, Lohr JM, et al. Venous hemodynamic changes during laparoscopic cholecystectomy. J Laparoendosc Surg. 1995;5:363–9.CrossRefPubMed Sobolewski AP, Deshmukh RM, Brunson BL, McDevitt DT, VanWagenen TM, Lohr JM, et al. Venous hemodynamic changes during laparoscopic cholecystectomy. J Laparoendosc Surg. 1995;5:363–9.CrossRefPubMed
22.
Zurück zum Zitat Gargiulo NJ 3rd, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E, et al. The incidence of pulmonary embolism in open versus laparoscopic gastric bypass. Ann Vasc Surg. 2007;21:556–9.CrossRefPubMed Gargiulo NJ 3rd, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E, et al. The incidence of pulmonary embolism in open versus laparoscopic gastric bypass. Ann Vasc Surg. 2007;21:556–9.CrossRefPubMed
23.
Zurück zum Zitat Sugerman HJ, Sugerman EL, Wolfe L, Kellum JM Jr, Schweitzer MA, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41–6.CrossRefPubMedPubMedCentral Sugerman HJ, Sugerman EL, Wolfe L, Kellum JM Jr, Schweitzer MA, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41–6.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Frezza EE, Wachtel MS. A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery. Obesity (Silver Spring). 2006;14:1961–5.CrossRef Frezza EE, Wachtel MS. A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery. Obesity (Silver Spring). 2006;14:1961–5.CrossRef
25.
Zurück zum Zitat Gargiulo NJ 3rd, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E. Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg. 2006;44:1301–5.CrossRefPubMed Gargiulo NJ 3rd, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E. Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg. 2006;44:1301–5.CrossRefPubMed
26.
Zurück zum Zitat Prystowsky JB, Morasch MD, Eskandari MK, Hungness ES, Nagle AP. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery. 2005;138:759–63. discussion 763-5.CrossRefPubMed Prystowsky JB, Morasch MD, Eskandari MK, Hungness ES, Nagle AP. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery. 2005;138:759–63. discussion 763-5.CrossRefPubMed
27.
Zurück zum Zitat Trigilio-Black CM, Ringley CD, McBride CL, Sorensen VJ, Thompson JS, Longo GM, et al. Inferior vena cava filter placement for pulmonary embolism risk reduction in super morbidly obese undergoing bariatric surgery. Surg Obes Relat Dis. 2007;3:461–4.CrossRefPubMed Trigilio-Black CM, Ringley CD, McBride CL, Sorensen VJ, Thompson JS, Longo GM, et al. Inferior vena cava filter placement for pulmonary embolism risk reduction in super morbidly obese undergoing bariatric surgery. Surg Obes Relat Dis. 2007;3:461–4.CrossRefPubMed
28.
Zurück zum Zitat Obeid FN, Bowling WM, Fike JS, Durant JA. Efficacy of prophylactic inferior vena cava filter placement in bariatric surgery. Surg Obes Relat Dis. 2007;3:606–8. discussion 609-10.CrossRefPubMed Obeid FN, Bowling WM, Fike JS, Durant JA. Efficacy of prophylactic inferior vena cava filter placement in bariatric surgery. Surg Obes Relat Dis. 2007;3:606–8. discussion 609-10.CrossRefPubMed
29.
Zurück zum Zitat Halmi D, Kolesnikov E. Preoperative placement of retrievable inferior vena cava filters in bariatric surgery. Surg Obes Relat Dis. 2007;3:602–5.CrossRefPubMed Halmi D, Kolesnikov E. Preoperative placement of retrievable inferior vena cava filters in bariatric surgery. Surg Obes Relat Dis. 2007;3:602–5.CrossRefPubMed
30.
Zurück zum Zitat Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg. 2000;10:7–13. discussion 14.CrossRefPubMed Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg. 2000;10:7–13. discussion 14.CrossRefPubMed
31.
Zurück zum Zitat Gugliotti DV. What is the optimal venous thromboembolism prophylaxis for patients undergoing bariatric surgery? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit. Cleve Clin J Med. 2006;73(Electronic Suppl 1):S17–8.CrossRefPubMed Gugliotti DV. What is the optimal venous thromboembolism prophylaxis for patients undergoing bariatric surgery? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit. Cleve Clin J Med. 2006;73(Electronic Suppl 1):S17–8.CrossRefPubMed
32.
Zurück zum Zitat Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12:19–24.CrossRefPubMed Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12:19–24.CrossRefPubMed
33.
Zurück zum Zitat Kalfarentzos F, Stavropoulou F, Yarmenitis S, Kehagias I, Karamesini M, Dimitrakopoulos A, et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg. 2001;11:670–6.CrossRefPubMed Kalfarentzos F, Stavropoulou F, Yarmenitis S, Kehagias I, Karamesini M, Dimitrakopoulos A, et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg. 2001;11:670–6.CrossRefPubMed
34.
Zurück zum Zitat Shuhaiber J, Vitello J. Is gastric bypass associated with more complications in patients weighing >500 lb (>227 kg)? Obes Surg. 2004;14:43–6.CrossRefPubMed Shuhaiber J, Vitello J. Is gastric bypass associated with more complications in patients weighing >500 lb (>227 kg)? Obes Surg. 2004;14:43–6.CrossRefPubMed
35.
Zurück zum Zitat Shepherd MF, Rosborough TK, Schwartz ML. Heparin thromboprophylaxis in gastric bypass surgery. Obes Surg. 2003;13:249–53.CrossRefPubMed Shepherd MF, Rosborough TK, Schwartz ML. Heparin thromboprophylaxis in gastric bypass surgery. Obes Surg. 2003;13:249–53.CrossRefPubMed
36.
Zurück zum Zitat Shepherd FM, Rosborough TK, Schwartz ML. Unfractionated heparin infusion for thromboprophylaxis in highest risk gastric bypass surgery. Obes Surg. 2004;14:601–5. 18.CrossRef Shepherd FM, Rosborough TK, Schwartz ML. Unfractionated heparin infusion for thromboprophylaxis in highest risk gastric bypass surgery. Obes Surg. 2004;14:601–5. 18.CrossRef
37.
Zurück zum Zitat Paige JT, Gouda BP, Gaitor-Stampley V, Scalia PG, Klainer TE, Raum WJ, et al. No correlation between anti-factor Xa levels, low-molecular-weight heparin, and bleeding after gastric bypass. Surg Obes Relat Dis. 2007;3:469–75.CrossRefPubMed Paige JT, Gouda BP, Gaitor-Stampley V, Scalia PG, Klainer TE, Raum WJ, et al. No correlation between anti-factor Xa levels, low-molecular-weight heparin, and bleeding after gastric bypass. Surg Obes Relat Dis. 2007;3:469–75.CrossRefPubMed
38.
Zurück zum Zitat Rocha AT, de Vasconcellos AG, da Luz Neto ER, Araújo DM, Alves ES, Lopes AA. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2006;16:1645–55.CrossRefPubMed Rocha AT, de Vasconcellos AG, da Luz Neto ER, Araújo DM, Alves ES, Lopes AA. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2006;16:1645–55.CrossRefPubMed
39.
Zurück zum Zitat Carmody BJ, Sugerman H, Kellum JM, Jamal MK, Johnson JM, Carbonell AM, et al. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution’s 24-year experience. J Am Coll Surg. 2006;203:831–6.CrossRefPubMed Carmody BJ, Sugerman H, Kellum JM, Jamal MK, Johnson JM, Carbonell AM, et al. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution’s 24-year experience. J Am Coll Surg. 2006;203:831–6.CrossRefPubMed
40.
Zurück zum Zitat Gonzalez R, Haines K, Nelson LG, Gallagher SF, Murr MM. Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:30–5. discussion 35-6.CrossRefPubMed Gonzalez R, Haines K, Nelson LG, Gallagher SF, Murr MM. Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:30–5. discussion 35-6.CrossRefPubMed
41.
Zurück zum Zitat Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003;13:819–25.CrossRefPubMed Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003;13:819–25.CrossRefPubMed
42.
Zurück zum Zitat Mason EE, Renquist KE, Jiang D. Perioperative risks and safety of surgery for severe obesity. Am J Clin Nutr. 1992;55(2 Suppl):573S–6.CrossRefPubMed Mason EE, Renquist KE, Jiang D. Perioperative risks and safety of surgery for severe obesity. Am J Clin Nutr. 1992;55(2 Suppl):573S–6.CrossRefPubMed
43.
Zurück zum Zitat Holmes NJ, Brolin RE, Kaufman JL. Is morbid obesity a risk factor for postoperative venous thromboembolism? Complications in Surgery. 1996;13:23–8. Holmes NJ, Brolin RE, Kaufman JL. Is morbid obesity a risk factor for postoperative venous thromboembolism? Complications in Surgery. 1996;13:23–8.
44.
Zurück zum Zitat Husemann B, Reiners V. Initial outcome of vertical gastroplasty in treatment of morbid obesity. Zentralbl Chir. 1996;121:370–5.PubMed Husemann B, Reiners V. Initial outcome of vertical gastroplasty in treatment of morbid obesity. Zentralbl Chir. 1996;121:370–5.PubMed
45.
Zurück zum Zitat Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.CrossRefPubMed Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.CrossRefPubMed
46.
Zurück zum Zitat Semple CW, Chehata A, Wilkinson S, Wertheimer MA. Laparoscopic adjustable gastric banding: initial Tasmanian experience. ANZ J Surg. 2003;73(8):594–6.CrossRefPubMed Semple CW, Chehata A, Wilkinson S, Wertheimer MA. Laparoscopic adjustable gastric banding: initial Tasmanian experience. ANZ J Surg. 2003;73(8):594–6.CrossRefPubMed
47.
Zurück zum Zitat Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T, et al. Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2004;18:1082–4.PubMed Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T, et al. Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2004;18:1082–4.PubMed
48.
Zurück zum Zitat Cotter SA, Cantrell W, Fisher B, Shopnick R. Efficacy of venous thromboembolism prophylaxis in morbidly obese patients undergoing gastric bypass surgery. Obes Surg. 2005;15:1316–20.CrossRefPubMed Cotter SA, Cantrell W, Fisher B, Shopnick R. Efficacy of venous thromboembolism prophylaxis in morbidly obese patients undergoing gastric bypass surgery. Obes Surg. 2005;15:1316–20.CrossRefPubMed
49.
Zurück zum Zitat Quebbemann BB, Dallal RM. The orientation of the antecolic Roux limb markedly affects the incidence of internal hernias after laparoscopic gastric bypass. Obes Surg. 2005;15:766–70. discussion 770.CrossRefPubMed Quebbemann BB, Dallal RM. The orientation of the antecolic Roux limb markedly affects the incidence of internal hernias after laparoscopic gastric bypass. Obes Surg. 2005;15:766–70. discussion 770.CrossRefPubMed
50.
Zurück zum Zitat Heffline MS. Preventing vascular complications after gastric bypass. J Vasc Nurs. 2006;24:50–4. quiz 55.CrossRefPubMed Heffline MS. Preventing vascular complications after gastric bypass. J Vasc Nurs. 2006;24:50–4. quiz 55.CrossRefPubMed
51.
Zurück zum Zitat Angstadt J, Whipple O. Developing a new bariatric surgery program. Am Surg. 2007;73:1092–7.PubMed Angstadt J, Whipple O. Developing a new bariatric surgery program. Am Surg. 2007;73:1092–7.PubMed
52.
Zurück zum Zitat Cossu ML, Pilo L, Piseddu G, Tilocca PL, Cossu F, Noya G. Prophylaxis of venous thromboembolism in bariatric surgery. Chir Ital. 2007;59:331–5.PubMed Cossu ML, Pilo L, Piseddu G, Tilocca PL, Cossu F, Noya G. Prophylaxis of venous thromboembolism in bariatric surgery. Chir Ital. 2007;59:331–5.PubMed
53.
Zurück zum Zitat Nguyen NT, Hinojosa M, Fayad C, Varela E, Wilson SE. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg. 2007;205:248–55.CrossRefPubMed Nguyen NT, Hinojosa M, Fayad C, Varela E, Wilson SE. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg. 2007;205:248–55.CrossRefPubMed
54.
Zurück zum Zitat Kothari SN, Lambert PJ, Mathiason MA. Best Poster Award. A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin. Am J Surg. 2007;194:709–11.CrossRefPubMed Kothari SN, Lambert PJ, Mathiason MA. Best Poster Award. A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin. Am J Surg. 2007;194:709–11.CrossRefPubMed
Metadaten
Titel
Evidence of Thromboembolism Prophylaxis in Bariatric Surgery—Results of a Quality Assurance Trial in Bariatric Surgery in Germany from 2005 to 2007 and Review of the Literature
verfasst von
Christine Stroh
D. Birk
R. Flade- Kuthe
M. Frenken
B. Herbig
S. Höhne
H. Köhler
V. Lange
K. Ludwig
R. Matkowitz
G. Meyer
P. Pick
Th. Horbach
S. Krause
L. Schäfer
M. Schlensak
E. Shang
T. Sonnenberg
M. Susewind
H. Voigt
R. Weiner
S. Wolff
A. M. Wolf
U. Schmidt
F. Meyer
H. Lippert
Th. Manger
Study Group Obesity Surgery
Publikationsdatum
01.07.2009
Verlag
Springer New York
Erschienen in
Obesity Surgery / Ausgabe 7/2009
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-9838-2

Weitere Artikel der Ausgabe 7/2009

Obesity Surgery 7/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.